Skip to search formSkip to main contentSkip to account menu

PK-10,169

Known as: PK10169, PK 10,169, PK-10169 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Enoxaparin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study
We evaluated the antithrombotic efficacy of the low molecular weight heparin (LMWH) fraction PK 10169 in nine consecutive… 
1986
1986
Low molecular weight heparin fraction PK 10169: a new therapeutic means for anticoagulant therapy?
To test the efficacy and safety of low molecular weight heparin (LMWH) fractions in thromboembolic diseases, 2 pilot studies were… 
1986
1986
Effect of heparin and heparin fractions on experimental abscess formation.
To evaluate the effectiveness of heparin and heparin fractions in decreasing abscess formation, rats were divided into six groups… 
1986
1986
[Low molecular weight heparin in extracorporeal circulation. 1st clinical applications].
The haemorrhagic complications inherent to the use of heparin during cardiac surgery led us, after a pilot experimental study, to… 
1986
1986
[Preliminary study of the use of low-molecular weight heparin to prevent thrombotic risk].
This study involved two stages: In vitro study. Three LMWHs, CY 216-CY 222 (Choay) and PK 10169 (Pharmuka), were compared to… 
1985
1985
A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
The depolymerized heparin fragment PK 10169 was compared with conventional mucosal sodium heparin. The inhibition of factors Xa… 
1985
1985
[Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169)].